Study Purpose:The aim of the study is to evaluate the interest of the determination of pNFH and NFL neurofilaments in serum for the diagnosis of ALS in patients with a diagnostic standoff after evaluation in an expert ALS center. The hypothesis is that one of these biomarkers, or their combined analysis, will make it possible to confirm or invalidate the diagnosis of ALS.
Not yet recruiting
Progressive Motor Neuron Disease Without Definite Diagnosis
Type of Intervention:
Study Chair(s)/Principal Investigator(s):
Coordinating Center Contact Information
Full Study Summary:
Assistance Publique - Hôpitaux de Paris
Estimated Study Start Date:
11 / 01 / 2021
Estimated Study Completion Date:
11 / 01 / 2023
Posting Last Modified Date:
10 / 14 / 2021
Date Study Added to neals.org:
10 / 14 / 2021
N/AInclusion criteria :
Subjects with first and/or second motor neuron disease, evolving clinically and/or electrically over at least 12 months, not meeting the diagnostic criteria for ALS (revised El Escorial criteria):
- Isolated peripheral motor neuron disease (at least one region of the PNM) OR
- Isolated central motor neuron involvement (at least two areas of the MNC) OR
- associated involvement of the MNP and MNC but in the presence of an associated pathology responsible for a persistent diagnostic doubt (double narrow cervical and lumbar canal, associated evolving cancer evoking a paraneoplastic syndrome without specific antibody found) Age superior to 18 years Management and follow-up in one of the French ALS centers Patient able to express his non-opposition Affiliation with social security or beneficiary of such a plan
Refusal of the patient Person under a legal protection measure (guardianship, curatorship or safeguard of justice).
Person deprived of liberty by judicial or administrative decision.